| | | | | |
| $0,60100 | +0,00% | $212,04M | $10,37M | |
PALO Paloma Acquisition Corp I Class A Ordinary Shares | $10,0000 | +0,50% | $211,84M | $17,00 | |
CCAQ Collective Acquisition Corp. Class A Ordinary Shares | $10,4700 | -0,44% | $211,83M | $1,35K | |
PLX Protalix BioTherapeutics, Inc. Common Stock | $2,2200 | +0,00% | $211,09M | $975,77K | |
GORO Goldgroup Mining Inc. | $2,7500 | +0,00% | $211,07M | $1,21M | |
EGHA EGH Acquisition Corp. Class A Ordinary Shares | $10,3500 | -0,01% | $210,94M | $58,00 | |
OVBC Ohio Valley Banc Corp | $44,6650 | +0,21% | $210,72M | $24,79K | |
HAVA Harvard Ave Acquisition Corporation Class A Ordinary Share | $10,1500 | +0,00% | $210,03M | $10,00 | |
IPOD Dune Acquisition Corporation II Class A Ordinary Shares | $10,3800 | -0,38% | $210,01M | $263,00 | |
OSG Octave Specialty Group, Inc. | $4,9000 | +0,00% | $209,93M | $364,23K | |
PLG Platinum Group Metals LTD. | $1,4800 | +0,00% | $209,26M | $1,56M | |
NCMI National CineMedia, Inc. | $2,8650 | +0,18% | $208,83M | $1,40M | |
ANTA Antalpha Platform Holding Company Class A Ordinary Shares | $3,8550 | +7,68% | $208,49M | $977,00 | |
| $5,7500 | +1,05% | $208,38M | $612,35K | |
RNA Atrium Therapeutics, Inc. Common Stock | $12,8800 | +0,31% | $208,17M | $161,67K | |
